Scholarly article on topic 'Pichia stipitis xylose reductase helps detoxifying lignocellulosic hydrolysate by reducing 5-hydroxymethyl-furfural (HMF)'

Pichia stipitis xylose reductase helps detoxifying lignocellulosic hydrolysate by reducing 5-hydroxymethyl-furfural (HMF) Academic research paper on "Industrial Biotechnology"

0
0
Share paper
Academic journal
Biotechnol Biofuels
OECD Field of science
Keywords
{""}

Academic research paper on topic "Pichia stipitis xylose reductase helps detoxifying lignocellulosic hydrolysate by reducing 5-hydroxymethyl-furfural (HMF)"

Biotechnology for Biofuels

BioMed Central

Open Access

Research

Pichia stipitis xylose reductase helps detoxifying lignocellulosic hydrolysate by reducing 5-hydroxymethyl-furfural (HMF)

Joäo RM Almeida*1, Tobias Modig2, Anja Röder1'3, Gunnar Liden2 and Marie F Gorwa-Grauslund1

Address: department of Applied Microbiology, Lund University, P.O. Box 124, S-221 00 Lund, Sweden, 2Department of Chemical Engineering Lund University, P.O. Box 124, S-221 00 Lund, Sweden and 3Institut für Medizinische Mikrobiologie, Virologie und Hygiene, Universitätsklinikum Hamburg-Eppendorf, Campus Forschung, N27, 2. OG Martinistraße 52 20246, Hamburg, Germany

Email: Joäo RM Almeida* - joao.almeida@tmb.lth.se; Tobias Modig - tobias.modig@chemeng.lth.se; Anja Röder - anja.kruggel@web.de; Gunnar Liden - Gunnar.Liden@chemeng.lth.se; Marie-F Gorwa-Grauslund - Marie-Francoise.Gorwa@tmb.lth.se * Corresponding author

Published: 11 June 2008 Received: 6 March 2008

Biotechnology for Biofuels 2008, 1:12 doi:l0.1 186/1754-6834-1-12 Accepted: II June 2008

This article is available from: http://www.bi0techn0l0gyf0rbi0fuels.c0m/c0ntent/l/l/i2 © 2008 Almeida et al; licensee Bi0Med Central Ltd.

This is an Open Access article distributed under the terms 0f the Creative C0mm0ns Attributi0n License (http://creativec0mm0ns.0rg/licenses/by/2.0), which permits unrestricted use, distributi0n, and repr0ducti0n in any medium, provided the 0riginal w0rk is properly cited.

Abstract

Background: Pichia stipitis xyfose reductase (Ps-XR) has been used t0 design Saccharomyces cerevisiae strains that are able t0 ferment xyfose. One example is the industrial S. cerevisiae xyfose-c0nsuming strain TMB3400, which was ranstructed by expressfon 0f P. stipitis xyfose reductase and xylit0l dehydrogenase and 0verexpressi0n 0f end0gen0us xylufose kinase in the industrial S. cerevisiae strain USM2I.

Results: In this study, we dem0nstrate that strain TMB3400 n0t 0nly ranverts xyfose, but als0 displays higher tolerance to lign0cellufosic hydrolysate during anaerobic batch fermentatfon as well as 3 times higher in vitro HMF and furfural reductfon activity than the rantrol strain USM21. Using lab0rat0ry strains producing varfous levels 0f Ps-XR, we c0nfirm that Ps-XR is able to reduce HMF b0th in vitro and in vivo. Ps-XR 0verexpressi0n increases the in vivo HMF c0nversi0n rate by approximately 20%, thereby improving yeast tolerance towards HMF. Further purificatfon 0f Ps-XR sh0ws that HMF is a substrate inhibitor 0f the enzyme.

Conclusion: We dem0nstrate for the first time that xyfose reductase is als0 able to reduce the furaldehyde c0mp0unds that are present in undetoxified lign0cellul0sic hydrolysates. P0ssible implicati0ns 0f this newly characterized activity 0f Ps-XR 0n lign0cellul0sic hydr0lysate fermentati0n are discussed.

Background

Commercial production of bioethanol from lignocellulosic hydrolysate by yeast requires strains that (i) can ferment all sugars, both hexose and pentose sugars, in the hydroysate, and (ii) show sufficient tolerance to the inhibitors present in the hydrolysate [1,2]. Xylose-fermenting Saccharomyces cerevisiae strains have been constructed by heterologous overexpression of xylose isomerase (XI) or

xylose reductase and xylitol dehydrogenase (XR/XDH) pathways (reviewed in [3]). While in the XI pathway, xylose is directly converted to xylulose, in the XR/XDH pathway xylose is initially reduced to xylitol by XR, and then xylitol is oxidized to xylulose by XDH. So far, efficient fermentation of xylose in lignocellulosic hydro-lysates has been demonstrated for industrial S. cerevisiae strains carrying the XR/XDH pathway only [4-8].

In addition to hexoses and pentoses, the lignocellulosic hydrolysates may contain phenolic derivatives, acetic acid and the furaldehydes furfural and 5-hydroxymethyl-fur-fural (HMF) that inhibit yeast fermentation [2,9,10]. The effect on the metabolism in S. cerevisiae and the possible mechanisms conferring tolerance varies according to the nature of the inhibiting compound. For instance, tolerance to acetic acid is obtained by increasing ATPase activity, which pumps protons out of the cytoplasm [11], whereas tolerance towards furaldehydes and some phenolic derivatives is obtained by reduction of these compounds to less toxic alcohols [12-15]. Recently, a strong correlation between fermentation performances of S. cer-evisiae strains in lignocellulosic hydrolysate and their ability to reduce HMF and furfural to furan-2,5-dimethanol (FDM) and 2-furanmethanol (FM) has been highlighted [13,16-18]. Up to now, two S. cerevisiae enzymes, the alcohol dehydrogenase 6 (ADH6) and an alcohol dehydroge-nase 1 mutant (mut-ADH1) have been identified as enzymes responsible for the reduction of HMF and furfural in S. cerevisiae [12,19]. Overexpression of such enzymes in S. cerevisiae resulted in increased tolerance towards HMF and lignocellulosic hydrolysates [12,18,19].

The industrial xylose-fermenting strain TMB3400 was constructed by integration of Pichia stipitis XR/XDH pathway in the genome of USM21 followed by random mutagenesis [20]. In the current study, the fermentation performance of TMB3400 was compared with the parental strain USM21 in dilute acid spruce hydrolysate. The difference between the strains prompted us to investigate the putative role of P. stipitis XR (Ps-XR) in the response to furaldehyde inhibitors. In vitro and in vivo Ps-XR activity towards HMF was investigated in strains expressing Ps-XR at different levels and the kinetic properties of purified Ps-XR were also determined.

Results

Fermentation performance of TMB3400 and USM21 in spruce hydrolysate

The fermentation performance of the industrial xylose-consuming strain TMB3400 was compared with its parental strain USM21 in dilute acid spruce hydrolysate. The strains were grown in defined mineral medium supplemented with glucose and once the biomass concentration reached approximately 2.5 g/L, a pulse addition of one volume of spruce hydrolysate (i. e. 300 ml) was added to the fermentor. After addition of the hydrolysate, carbon dioxide evolution rate (CER), glucose consumption, etha-nol production and HMF and furfural conversion were followed (Fig. 1). Initially, the CER decreased rapidly for both strains. This is in agreement with what has been observed previously in similar types of addition experiments with spruce hydrolysates [16]. Thereafter, the CER was maintained at a constant level for approximately 8 h

20 30 Time (h)

0.5 :5

0.2 LL

0.5 :5

0.2 LL

10 20 30 Time (h)

Figure!

Fermentation profile of the control strain USM2! (top) and the xylose-fermenting strain TMB3400 (down) in batch fermentation of dilute-acid spruce hydrolysate. Strains were grown in defined mineral medium until biomass concentration reached approximately 2.5 g/L. Then hydrolysate was added at approximately time 18 hours (dashed line). CER is represented by the continuous line. Furfural (▲), HMF (•), Glucose (O), Ethanol (A). Data for USM21 is taken from [16].

for strain TMB3400, whereas it continued to decrease for the control strain USM21 (Fig. 1). Clearly, strain TMB3400 had a higher fermentation rate in spruce hydrolysate, which cannot be explained by the fermentation of the low level of xylose that was present in the hydrolysate. During the first 8 h after hydrolysate addition, the average specific ethanol productivity for USM21 and TMB3400 was 0.21 (g/g/h) (data from [16]) and 0.35 (g/g/h), respectively. The higher ethanol productivity obtained with TMB3400 correlated with a higher HMF reduction rate, 0.016 g/g/h compared with 0.007 g/g/h for USM21 (data from [16]). The concentration of furfural was too low in the hydrolysate to determine any significant difference in furfural conversion.

TMB3400 and USM2I reduction ability

The ability to ferment dilute acid hydrolysates has previously been associated with the ability to reduce furalde-hydes [16-18]. For this reason, HMF and furfural reduction in strains TMB3400 and USM21 were compared by in vitro measurements using crude extracts from cells grown aerobically in glucose. In parallel, XR activity was measured as a control. As expected, TMB3400 showed high XR activity while USM21 only displayed background activity (Fig. 2). Furthermore, the cofactor preference of Ps-XR was confirmed, i.e. XR activity was higher when using NADPH rather than NADH as cofactor (Fig. 2) [21]. Both strains were able to reduce HMF and furfural; however TMB3400 showed higher specific activity in most cases (Fig. 2). TMB3400 was able to reduce HMF using NADH or NADPH as co-factor, whereas USM21 showed 3 times lower activity with HMF either using NADH or NADPH as co-factor. NADH-dependent furfural reduction was high in both strains, but TMB3400 showed approximately 3-fold higher NADPH-dependent activity with furfural than USM21 (Fig. 2).

In vitro HMF and furfural reduction by Ps-XR

Since the industrial strain TMB3400 was obtained from USM21 not only by targeted integration of the xylose pathway but also by further random mutagenesis, three S. cerevisiae strains derived from the same strain background without mutagenesis, which produce Ps-XR at different levels were used to confirm that Ps-XR was the enzyme responsible for HMF and furfural improved reduction in TMB3400. The control strain TMB3290 does not produce Ps-XR, whereas TMB3001 produces low level of Ps-XR and TMB3260 overproduces Ps-XR [22]. All three strains were grown aerobically in defined mineral medium supplemented with glucose and used to prepare crude cell extracts for enzymatic measurement of xylose, HMF and furfural reduction (Fig. 3). As expected, the control strain showed only background activity for xylose, whereas TMB3001 and TMB3260 shown increased specific activity against xylose using both NADH and NADPH (Fig. 3). Ps-XR was able to reduce HMF and furfural but the specific activity was approximately 6 times lower than with xylose (Fig. 3). The higher Ps-XR, the higher HMF and furfural

m 1000 S

¡3 800

W 600 400

1200 1000 800 600 400 200 0

USM21 TMB3400

USM21 TMB3400

ig s Ü3 s

USM21 TMB3400

Figure2

Xylose (left graph), HMF (middle graph) and furfural (right graph) reduction activity measured in crude cell extracts from cells of strains USM2I and TMB3400. Cells were grown aerobically 0vernight in defined mineral medium. The assays were performed using NADH (top) 0r NADPH (b0tt0m) as c0fact0r. The values are averages 0f tw0 independent measurements. The bars represent the deviatfon from the average.

activity. As for TMB3400 (Fig. 2), Ps-XR HMF reduction was coupled with NADH and NADPH whereas furfural reduction was coupled only with NADPH (Fig. 3). Like for xylose, NADPH-dependent HMF reduction activity was higher than NADH-dependent activity (Fig. 3). All strains presented a high NADH-dependent furfural reduction activity (~1000 mU/mg), independent of Ps-XR level (Fig. 3).

In vivo HMF and furfural reduction by Ps-XR

In order to analyze the in vivo effects of Ps-XR overexpression in HMF and furfural reduction, batch fermentations in defined medium were performed with strains TMB3001 (control), TMB3260 (low Ps-XR) and TMB3290 (high Ps-XR) in the absence or presence of HMF or furfural. In the absence of inhibitor, all strains showed similar growth rates (Table 2) and product distribution (data not shown). In the presence of HMF, the control and TMB3001 strains presented similar grow rates whereas TMB3260 which overproduces Ps-XR had slightly higher growth rate and higher HMF reduction rate (Table 2, Fig.

4). In the presence of furfural, the growth rate of the three strains was also reduced but similar growth pattern and product distribution were observed for the three strains (data not shown).

XR purification and kinetic characterization

Ps-XR was purified from the overproducing strain TMB3260 in order to determine the kinetic properties with HMF as substrate. The purification using gel filtration and affinity chromatography (Table 3) provided a 12-fold enrichment of the enzyme to a final specific XR activity of 8000 mU.mg protein-1. The purity of the enzyme was confirmed by SDS-Page. The kinetics of xylose and arabinose reduction by Ps-XR could be described by a Michaelis-Menten model (equation 1),

y 1500 <

O 1000

300 -I

t5 150 H <

8 100 H

)2500 -

È3 2000 -

1500 -

u a oo

È3 200 -

TMB3290 TMB3001 TMB3260

m 1200

TMB3290 TMB3001 TMB3260

TMB3290 TMB3001 TMB3260

Figure3

Xylose (left graph), HMF (middle graph) and furfural (right graph) reduction activity measured in crude cell extracts from cells of strains TMB3290 (no Ps-XR), TMB300I (low Ps-XR) and TMB3260 (high Ps-XR). Cells were grown aerobically overnight in defined mineral medium. The assays were performed using NADH (top) or NADPH (bottom) as cofactor. The values are averages of two independent measurements. The bars represent the deviation from the average.

Table 1: Saccharomyces cerevisiae strains used in the study.

Strain

Description

Reference

USM2I Polyploid industrial strain

TMB3400 USM2I (his3:: YipXR/XDH/XK) + random mutagenesis - produces XR, XDH, XK

CEN.PK II3-7A Laboratory strain MATa his3-AI MAL2-8c SUC2

TMB3290 CEN.PK II3-7A (MATa his3-AI MAL2-8c SUC2) his3::YipXDH/XK - produces XDH, XK

TMB300I CEN.PK II3-7A (MATa his3-AI MAL2-8c SUC2) his3::YipXR/XDH/XK - produces XR, XDH, XK

TMB3260 TMB300I PGKIp-XYLl - Overproduces XR

[35] [20]

This work

in which the estimated Km values for xylose and arab-inose 89.5 and 50 mM, respectively, were in agreement with previous reports [22,23]. In contrast, HMF reduction did not follow Michaelis-Menten kinetics as HMF concentrations above 60 mM appeared to strongly inhibit the enzyme (Fig. 5). Instead, the experimental data best fitted a substrate-inhibition model including a hill coefficient (Equation 2; Fig. 5) [24].

'Km/s )+1+(s/K!-;

An inhibition coefficient (Ki) equal to 95.0 and a hill coefficient (n) = 3.51 were obtained in the calculations for the model best fit The apparent Km and Vmax with HMF as substrate were 40 mM and 0.37 |mol min-1 mg protein-1, respectively. The proportion of variance (R2 = 0.95) given by the model indicated a good fit to the experimental data (Fig. 5).

Discussion

S. cerevisiae NADPH-dependent alcohol dehydrogenase 6 (ADH6) and NADH-dependent alcohol dehydrogenase 1 mutant (mut-ADH1) have previously been identified as reductases able to reduce HMF, both in vitro and in vivo [12,19]. In this work, we demonstrate that P. stipitis xylose reductase (Ps-XR) can perform the same reaction using either NADH or NADPH. P. stipitis XYL1 gene encoding Ps-XR was the first XR gene to be efficiently expressed in S. cerevisiae [25-27] and Ps-XR was purified and the kinetic properties were determined for a wide range of substrates

Table 2: Specific growth rate and HMF consumption rate for strains growing aerobically on glucose mineral medium supplemented or not with 2 g/L HMF.

No HMF With HMF

^ (h-1) ^ (h-1) qHMF (g.g-l.h-i)*

Control 0.36 ± 0.01 0.20 ± 0.00 0.36 ± 0.02

Low Ps-XR 0.37 ± 0.00 0.20 ± 0.00 0.37 ± 0.02

High Ps-XR 0.36 ± 0.00 0.23 ± 0.01 0.45 ± 0.03

*Calculated after 6 hours.

[21-23]. However, XR activity towards lignocellulosic inhibitors has never previously been reported.

As for ADH6 or mut-ADH1 [12,18,19], overexpression of Ps-XR in laboratory strains increased tolerance towards HMF and improved growth in the presence of the inhibitor. However, in contrast with ADH6 and mut-ADH1, Ps-XR could use both NADH and NADPH in HMF reduction, which may be favorable since strict use of NADH or NADPH by the alcohol dehydrogenases appear to change product distribution in defined mineral medium [18].

Despite higher in vitro HMF reduction activity for the laboratory strain TMB3001 than for the industrial strain TMB 3400, in vivo improvement of HMF conversion rate in laboratory strains was only evident with the highest Ps-XR activity (strain TMB3260). Variation in the HMF conversion rate and fermentation performance among the industrial and laboratory strains might be related with the experimental conditions. The industrial strains were evaluated under anaerobic conditions in hydrolysate containing media whereas the laboratory strains were tested under aerobic conditions in defined mineral medium supplemented with HMF. The industrial strains were exposed simultaneously to HMF, furfural, acetic acid and phenolic derivatives, which can have synergistic inhibitory effects on yeast [28]. Therefore the in vivo advantage given by Ps-XR may have been more easily distinguishable in TMB3400 than in the laboratory strains because the industrial strains were dealing and converting different compounds concurrently, with resulting low HMF reduction rate. The higher background for HMF and furfural reduction activities in the control strains might also have contributed to the absence of in vivo improvement of the laboratory strain with low Ps-XR level (TMB3001). The control strain USM21 had total furaldehyde reduction activity 3.5 times lower than the control TMB3290 (~270 mU/mg protein and ~940 mU/mg protein).

A possible role of Ps-XR in the in vivo conversion of other compounds like furfural and phenolics derivatives cannot be excluded. For instance, the in vitro Ps-XR ability to reduce furfuralwas demonstrated, but strains overexpress-ing this enzyme did not show any significant improve-

ment in the fermentation performance in the presence of this inhibitor.

As demonstrated by kinetics studies, HMF inhibits alcohol dehydrogenase (ADH; EC 1.1.1.1), aldehyde dehydrogenase (AlDH; EC 1.2.1.5) and the pyruvate dehydrogenase (PDH) activities in vitro [29]. In our study, we demonstrated that HMF was also a substrate-inhibitor of Ps-XR, although the strongest inhibitory effects appeared when concentrations above 60 mM HMF were used. Considering that HMF concentrations in different hydrolysates vary between 10 mM and 40 mM, the HMF inhibition effects on Ps-XR are most probably not present in vivo. However, further studies may be required to analyze the in vivo Ps-XR response to HMF and the intracellular HMF level in yeast.

Conclusion

We demonstrate for the first time that Ps-XR has furalde-hyde reduction abilities, which helps S. cerevisiae detoxifying spruce hydrolysate. These results indicate a possible advantage in using XR instead of XI pathway for the construction of recombinant S. cerevisiae strains to be used in hydrolysates with high HMF content.

Methods Yeast strains

Saccharomyces cerevisiae strains used in this work are listed in Table 1. The strains were maintained on agar plates containing yeast nitrogen base medium (YNB) (Difco YNB without amino acids 6.7 g/L) and 20 g/L glucose.

Fermentation in spruce hydrolysate

The growth medium in inoculum cultures was a defined medium according to [30]. The hydrolysate used was produced from forest residue originating mainly from spruce in a two-stage dilute-acid hydrolysis process using sulphuric acid as the catalyst [31]. The composition of the hydrolysate was 24.3 g/l glucose, 12.1 g/l mannose, 2.9 g/l galactose, 5.6 g/l xylose, 1.4 g/l arabinose, 2.0 g/l acetic acid, 1.9 g/l HMF, and 0.5 g/l furfural. Adjustment of the hydrolysate to pH 5 with 6 M NaOH was made prior to use.

0 E№

-A - 0.5

2.0 1.5 1.0 0.5 0.0

0 4 8 12 16 20 24 Time (h)

Figure4

Glucose batch fermentation with the S. cerevisiae strains TMB3290 (control - top), TMB300I (low Ps-XR - middle) and TMB3260 (high Ps-XR - bottow) in the presence of 2 g/L HMF. Glucose (O), HMF (•), biomass (□) and ethanol (A). The experiments were done in duplicate and the figure shows a representative profile for each strain.

The inoculum cultures were grown in 300 ml cotton plugged shake-flasks containing 100 ml media supplemented with 15 g/l glucose in a rotary shaker at 160 rpm

and at 30°C for 24 h. Batch fermentations were inoculated with 6 ml of the preculture and carried out in Belach BR 0.5 fermentors (Belach Bioteknik AB, Solna, Sweden).

Table 3: Purification of Pichia stipitis XR from strain TMB3260 grown in defined mineral medium supplemented with glucose.

Method Amount Protein (mg) Total Activity (U) Specific Activity (U/mg) Purification fold

X-Press 725 478.5 0.66 1

Red-Sepharose 9 32.5 3.61 5.5

Gel Filtration 2.8 22.5 8.04 12.2

Figure5

Measured (black boxes) and model (line) values of HMF conversion rate obtained with Pichia stipitis xylose reductase.

samples were immediately centrifuged, filtered through 0.2 |m filters and stored at -20°C until analysis. The concentrations of ethanol, glycerol and acetic acid were analyzed using HPLC system (Waters, Milford, Massachusetts, USA) equipped with Aminex HPX-87H column (Bio-Rad, Hercules, California) at 45 °C. The mobile phase was 5 mM sulphuric acid with a flow of 0.6 ml/min. The concentrations of glucose, mannose, galactose, xylose, arabinose, HMF and furfural were measured on an Aminex HPX-87P column (Bio-Rad, USA) at 85°C, eluted with ultra-pure water at 0.6 ml/min. All compounds were detected with a refractive index detector, except for HMF and furfural which were detected with a UV-detector (210 nm). The carbon dioxide evolution rate was monitored on-line by measuring the concentrations of carbon dioxide and oxygen in the outgoing gas from the reactor with a CP460 gas analyser (Belach Bioteknik AB, Solna, Sweden). The gas analyzer was calibrated using a gas containing 20% oxygen and 5% carbon dioxide.

Initial concentrations of medium components were 2.67 times higher compared to the inoculum cultures in order to compensate for the dilution. The batch fermentations were started by growing cells on 30 g of glucose in an initial working volume of 300 mL. Next, a single addition of 300 ml of hydrolysate was made when growth reached mid/late exponential phase, which corresponded to a biomass concentration of approximately 2.5 g/l in the reactor. The stirrer speed and the temperature were 600 rpm and 30°C, respectively. The pH was kept constant at 5.0 by addition of 0.75 NaOH. Anaerobic conditions were obtained by continuously sparging the fermentor with 0.3 L/min nitrogen gas, which was controlled by a mass flow meter (Bronkhurst Hi-Tec, Ruurlo, The Netherlands).

In vivo HMF and furfural reduction by Ps-XR

Inoculum cultures were grown overnight at 30°C in 250 mL cotton plugged shake-flasks with 25 mL of double-concentrated defined mineral medium (46) supplemented with 40 g L-1 glucose and 200 ml L-1 phthalate buffer (10.2 g/L medium KH phthalate, 2.2 g/l medium KOH). The same media was used in the growth curves, except for the addition of 2 g/l HMF where indicated. Growth curves were started at OD620 0.5 and were carried out in 100 mL media at 30°C in 1 L cotton plugged shake-flasks. The stirring rate was 200 rpm. Samples for biomass measurements were withdrawn regularly.

Biomass and metabolites

Cell concentration was determined from absorbance measurements at 610 nm and dry-weight measurements were made from duplicate 10 ml samples, which were centrifuged, washed with distilled water and dried for 24 h at 105 °C. The biomass concentration was correlated with OD by the dry weight measurements. The metabolite

Enzymatic activity measurements

Cell extracts were prepared with Y-PER reagent following the recommendations of the supplier (Pierce, Rockford, IL). The protein content in the cell free preparation was determined using Micro BCA Protein Assay Kit (Pierce). XR activity was measured in cell free extracts based on [32]. The reaction mixture contained 115 |M NAD(P)H and the reaction was started by adding 350 mM xylose in 100 mM Triethanolamine buffer (pH 7.0). Reductions of HMF and furfural reduction were measured as described in [33]. The reactions were performed in 100 mM phosphate buffer (pH 7.0) (50 mM KH2PO4 and 50 mM K2HPO4) and NAD(P)H was added to a concentration of 100 |M. The reaction was started by addition of 10 mM HMF or furfural. All assays were performed at 30°C and the oxidation of NAD(P)H was followed as the change in absorbance at 340 nm.

Xylose reductase purification

Cells of TMB3260 from aerobic batch fermentation in 1.5 L defined medium [11] supplemented with 40 g glucose were used as starting material for the purification of XR. Once the culture reached early-stationary phase, the cells were harvested and used for Ps-XR purification following the protocol described in [22]. All purification steps were carried out at 4°C, and 5 mM 2-mercaptoethanol was added in all buffers to stabilize the enzyme activities. After each purification-step the enzyme activity of the different fractions were measured and the purification was proofed by SDS-gel-electrophoresis.

Kinetic parameters

The kinetic constants for Ps-XR were determined using different substrates and NADPH as cofactor. The kinetic parameters Vmax (| mol min-1 mg protein-1) and the

Michaelis-Menten constant Km (mM) were estimated using non-liner regression analysis. The non-linear least-squares statistic tool from Microsoft-Excel (Microsoft) was used to parameter fitting. Typically, duplicate measurements at 10 different substrate concentrations spanning the Km value were used.

Construction of TMB3290

Plasmid YIpXRXDHXK [34] containing the overexpression cassettes for XR and XDH from P. stipitis and xyluloki-nase from S. cerevisiae was cut with BamHI. The restriction generated 3 fragments: 1.5 Kb XR cassette, 1.0 Kb HIS3 gene and the 12 Kb remaining plasmid. The HIS3 gene was re-ligated into the plasmid and used to transform DH5a Escherichia coli cells. The final plasmid YIpXDHXK, which does not express XR was used to transform S. cere-visiae CEN.PK113-7A. The positive clones were selected by growth in YNB media without amino acids and the strain was named TMB3290.

Competing interests

The authors declare that they have no competing interests. Authors' contributions

JRMA performed the genetic work, enzymatic activity measurements, experiments with in vivo HMF reduction by Ps-XR, participated in the kinetic data analysis and drafted the manuscript. TM carried out the fermentation in hydrolysate and participated in the kinetic data analysis. AR performed the Ps-XR purification and participated in the kinetic data analysis. GL participated in the study design and its coordination. MFGG participated in the study design and its coordination and helped to draft the manuscript. All authors reviewed and approved the final manuscript.

Acknowledgements

This work was sponsored by the Swedish Energy Administration and the Swedish Foundation for International Cooperation in Research and Higher Education (STINT)

References

1. Hahn-Hagerdal B, Karhumaa K, Fonseca C, Spencer-Martins I, Gorwa-Grauslund MF: Towards industrial pentose-fermenting yeast strains. Applied Microbiology and Biotechnology 2007, 74:937-953.

2. Almeida JRM, Modig T, Petersson A, Hahn-Hagerdal B, Lidén G, Gorwa-Grauslund MF: Increased tolerance and conversion of inhibitors in lignocellulosic hydrolysates by Saccharomyces cerevisiae. Journal of Chemical Technology & Biotechnology 2007, 82:340-349.

3. Chu BC, Lee H: Genetic improvement of Saccharomyces cerevisiae for xylose fermentation. Biotechnol Adv 2007.

4. Ohgren K, Bengtsson O, Gorwa-Grauslund MF, Galbe M, Hahn-Hag-erdal B, Zacchi G: Simultaneous saccharification and co-fermentation of glucose and xylose in steam-pretreated corn stover at high fiber content with Saccharomyces cerevisiae TMB3400. J Biotechnol 2006, 126:488-98.

5. Olsson L, Soerensen HR, Dam BP, Christensen H, Krogh KM, Meyer AS: Separate and simultaneous enzymatic hydrolysis and fermentation of wheat hemicellulose with recombinant xylose

utilizing Saccharomyces cerevisiae. Appl Biochem Biotechnol 2006, 129-132:117-129.

6. Sedlak M, Ho NW: Production of ethanol from cellulosic biomass hydrolysates using genetically engineered Saccharomyces yeast capable of cofermenting glucose and xylose. Appl Biochem Biotechnol 2004, 113-116:403-416.

7. Hahn-Hägerdal B, Pamment N: Microbial pentose metabolism. Appl Biochem Biotechnol 2004, 113-116:1207-1209.

8. Katahira S, Mizuike A, Fukuda H, Kondo A: Ethanol fermentation from lignocellulosic hydrolysate by a recombinant xylose-and cellooligosaccharide-assimilating yeast strain. Appl Microbiol Biotechnol 2006, 72:1 136-1143.

9. Palmqvist E, Hahn-Hägerdal B: Fermentation of lignocellulosic hydrolysates. II: inhibitors and mechanisms of inhibition. Bioresource Technology 2000, 74:25-33.

10. Klinke HB, Thomsen AB, Ahring BK: Inhibition of ethanol-pro-ducing yeast and bacteria by degradation products produced during pre-treatment of biomass. Appl Microbiol Biotechnol 2004, 66:10-26.

11. Verduyn C, Postma E, Scheffers WA, Van Dijken JP: Effect of ben-zoic acid on metabolic fluxes in yeasts: a continuous-culture study on the regulation of respiration and alcoholic fermentation. Yeast 1992, 8:501-517.

12. Petersson A, Almeida JRM, Modig T, Karhumaa K, Hahn-Hägerdal B, Gorwa-Grauslund MF, Liden G: A 5-hydroxymethyl furfural reducing enzyme encoded by the Saccharomyces cerevisiae ADH6 gene conveys HMF tolerance. Yeast 2006, 23:455-464.

13. Liu ZL, Slininger PJ, Dien BS, Berhow MA, Kurtzman CP, Gorsich SW: Adaptive response of yeasts to furfural and 5-hydroxymeth-ylfurfural and new chemical evidence for HMF conversion to 2,5-bis-hydroxymethylfuran. J Ind Microbiol Biotechnol 2004, 31:345-352.

14. Larsson S, Nilvebrant NO, Jonsson LJ: Effect of overexpression of Saccharomyces cerevisiae Padlp on the resistance to pheny-lacrylic acids and lignocellulose hydrolysates under aerobic and oxygen-limited conditions. Appl Microbiol Biotechnol 2001, 57:167-174.

15. Larsson S, Cassland P, Jonsson LJ: Development of a Saccharo-myces cerevisiae strain with enhanced resistance to phenolic fermentation inhibitors in lignocellulose hydrolysates by heterologous expression of laccase. Appl Environ Microbiol 2001, 67:1163-1170.

16. Modig T, Almeida JRM, Gorwa-Grauslund MF, Liden G: Variability of Saccharomyces cerevisiae strain response to lignocellulose hydrolysate. Biotechnology and Bioengineering 2008.

17. Nilsson A, Gorwa-Grauslund MF, Hahn-Hägerdal B, Liden G: Cofac-tor dependence in furan reduction by Saccharomyces cerevisiae in fermentation of acid-hydrolyzed lignocellulose. Appl Environ Microbiol 2005, 71:7866-7871.

18. Almeida JRM, Röder A, Modig T, Laadan B, Lidén G, Gorwa-Graus-lund MF: NADH- vs. NADPH-coupled reduction of 5-hydroxymethyl-furfural (HMF) and its implications on product distribution in Saccharomyces cerevisiae. Appl Microbiol Biotechnol 2008, 78(6):939-45.

19. Laadan B, Almeida JR, Radstrom P, Hahn-Hägerdal B, Gorwa-Graus-lund M: Identification of an NADH-dependent 5-hydroxymethylfurfural-reducing alcohol dehydrogenase in Saccharomyces cerevisiae. Yeast 2008, 25:191-198.

20. Wahlbom CF, van Zyl WH, Jonsson LJ, Hahn-Hägerdal B, Otero RR: Generation of the improved recombinant xylose-utilizing Saccharomyces cerevisiae TMB 3400 by random mutagenesis and physiological comparison with Pichia stipitis CBS 6054. FEMS Yeast Res 2003, 3:319-326.

21. Verduyn C, Van Kleef R, Frank J, Schreuder H, Van Dijken JP, Scheffers WA: Properties of the NAD(P)H-dependent xylose reductase from the xylose-fermenting yeast Pichia stipitis. Biochem J 1985, 226:669-677.

22. Jeppsson M, Traff K, Johansson B, Hahn-Hägerdal B, Gorwa-Graus-lund MF: Effect of enhanced xylose reductase activity on xylose consumption and product distribution in xylose-fermenting recombinant Saccharomyces cerevisiae. FEMS Yeast Res 2003, 3:167-175.

23. Rizzi M, Erlemann P, Bui-Thanh N-A, Dellweg H: Xylose fermentation by yeasts. 4. Purification and kinetic studies of xylose reductase from Pichia stipitis. Applied Microbiology and Biotechnology 1988, 29:148-154.

24. Eisenthal R: Enzyme Assays: A Practical Approach Oxford: Oxford University Press; I992.

25. Amore R, Kotter P, Kuster C, Ciriacy M, Hollenberg CP: Cloning and expression in Saccharomyces cerevisiae of the NAD(P)H-dependent xylose reductase-encoding gene (XYLI) from the xylose-assimilating yeast Pichia stipitis. Gene I99I, 109:89-97.

26. Hallborn J, Walfridsson M, Airaksinen U, Ojamo H, Hahn-Hagerdal B, Penttila M, Kerasnen S: Xylitol production by recombinant Saccharomyces cerevisiae. Biotechnology (N Y) I99I, 9:1090-I095.

27. Takuma S, Nakashima N, Tantirungkij M, Kinoshita S, Okada H, Seki T, Yoshida T: Isolation of xylose reductase gene of Pichia stipitis and its expression in Saccharomyces cerevisiae. Appl Bio-chem Biotechnol I99I, 28-29:327-340.

28. Taherzadeh MJ, Gustafsson L, Niklasson C, Liden G: Physiological effects of 5-hydroxymethylfurfural on Saccharomyces cerevisiae. Appl Microbiol Biotechnol 2000, 53:701-708.

29. Modig T, Liden G, Taherzadeh MJ: Inhibition effects of furfural on alcohol dehydrogenase, aldehyde dehydrogenase and pyruvate dehydrogenase. Biochem J 2002, 363:769-776.

30. Taherzadeh MJ, Liden G, Gustafsson L, Niklasson C: The effects of pantothenate deficiency and acetate addition on anaerobic batch fermentation of glucose by Saccharomyces cerevisiae. Appl Microbiol Biotechnol 1996, 46:176-182.

31. Nilsson A, Taherzadeh MJ, Liden G: Use of dynamic step response for control of fed-batch conversion of lignocellu-losic hydrolyzates to ethanol. J Biotechnol 200I, 89:41 -53.

32. Smiley K, Bolen P: Demonstration of D-xylose reductase and D-xylitol dehydrogenase in Pachysolen tannophilus. Biotechnol Lett I982, 9:.

33. Wahlbom CF, Hahn-Hagerdal B: Furfural, 5-hydroxymethyl furfural, and acetoin act as external electron acceptors during anaerobic fermentation of xylose in recombinant Saccharomyces cerevisiae. Biotechnol Bioeng 2002, 78: I72-178.

34. Eliasson A, Christensson C, Wahlbom CF, Hahn-Hagerdal B: Anaerobic xylose fermentation by recombinant Saccharomyces cerevisiae carrying XYLI, XYL2, and XKSI in mineral medium chemostat cultures. Appl Environ Microbiol 2000, 66:338I-3386.

35. Westhuizen TJ van der, Pretorius IS: The value of electrophoretic fingerprinting and karyotyping in wine yeast breeding programmes. Antonie Van Leeuwenhoek I992, 61:249-257.

36. Entian K-D, Koetter P: Yeast mutant and plasmid collections Academic Press, London, United Kingdom; I998.

Publish with BioMedCentral and every scientist can read your work free of charge

"BioMed Central will be the most significant development for disseminating the results of biomedical research in our lifetime." Sir Paul Nurse, Cancer Research UK

Your research papers will be:

• available free of charge to the entire biomedical community

• peer reviewed and published immediately upon acceptance

• cited in PubMed and archived on PubMed Central

• yours — you keep the copyright

Submit your manuscript here: i } BioMedcentral

http://www.biomedcentral.com/info/publishing_adv.asp ^